UnitedHealth Group (UNH) Sees a More Significant Dip Than Broader Market: Some Facts to Know

UnitedHealth Group (UNH) ended the recent trading session at $280.44, demonstrating a -1.37% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 0.28% for the day. Meanwhile, the Dow lost 0.44%, and the Nasdaq, a tech-heavy index, lost 0.28%. The largest U.S. health insurer's stock has dropped by 1.34% in the past month, exceeding the Medical sector's loss of 7.53% and the S&P 500's loss of 3.59%.Investors will be eagerly watching for the performance of UnitedHealth Group in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on April 21, 2026. It is anticipated that the company will report an EPS of $6.76, marking a 6.11% fall compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $110.26 billion, up 0.62% from the prior-year quarter. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $17.7 per share and revenue of $440.44 billion, indicating changes of +8.26% and -1.59%, respectively, compared to the previous year. Investors should also take note of any recent adjustments to analyst estimates for UnitedHealth Group. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, there's been a 0.02% rise in the Zacks Consensus EPS estimate. UnitedHealth Group is currently sporting a Zacks Rank of #3 (Hold). In terms of valuation, UnitedHealth Group is presently being traded at a Forward P/E ratio of 16.07. This denotes no noticeable deviation relative to the industry average Forward P/E of 16.07. It is also worth noting that UNH currently has a PEG ratio of 1.31. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. By the end of yesterday's trading, the Medical - HMOs industry had an average PEG ratio of 0.93. The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 226, which puts it in the bottom 8% of all 250+ industries. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. You can find more information on all of these metrics, and much more, on Zacks.com. Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks